Savant Capital LLC Has $378,000 Stake in Danaher Corporation (DHR)
Savant Capital LLC held its position in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,480 shares of the conglomerate’s stock at the close of the second quarter. Savant Capital LLC’s holdings in Danaher Corporation were worth $378,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in the company. Tirschwell & Loewy Inc. raised its stake in shares of Danaher Corporation by 2.1% during the second quarter. Tirschwell & Loewy Inc. now owns 242,435 shares of the conglomerate’s stock valued at $20,459,000 after acquiring an additional 4,904 shares during the last quarter. Pinnacle Financial Partners Inc. raised its stake in shares of Danaher Corporation by 17.4% during the second quarter. Pinnacle Financial Partners Inc. now owns 18,620 shares of the conglomerate’s stock valued at $1,572,000 after acquiring an additional 2,756 shares during the last quarter. Pitcairn Co. raised its stake in shares of Danaher Corporation by 4.5% during the second quarter. Pitcairn Co. now owns 49,703 shares of the conglomerate’s stock valued at $4,194,000 after acquiring an additional 2,141 shares during the last quarter. Bourgeon Capital Management LLC raised its stake in shares of Danaher Corporation by 2.7% during the second quarter. Bourgeon Capital Management LLC now owns 66,765 shares of the conglomerate’s stock valued at $5,634,000 after acquiring an additional 1,750 shares during the last quarter. Finally, Sigma Planning Corp raised its stake in shares of Danaher Corporation by 23.5% during the second quarter. Sigma Planning Corp now owns 4,928 shares of the conglomerate’s stock valued at $416,000 after acquiring an additional 937 shares during the last quarter. 75.68% of the stock is owned by hedge funds and other institutional investors.
In other Danaher Corporation news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the company’s stock in a transaction on Monday, July 31st. The shares were sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the transaction, the insider now directly owns 155,520 shares in the company, valued at approximately $12,718,425.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Linda P. Hefner sold 10,578 shares of the company’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $83.03, for a total transaction of $878,291.34. Following the completion of the transaction, the director now owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The disclosure for this sale can be found here. Insiders sold a total of 71,496 shares of company stock valued at $5,916,223 over the last 90 days. Company insiders own 12.20% of the company’s stock.
Several equities analysts have recently issued reports on the stock. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. Jefferies Group LLC reaffirmed a “buy” rating and set a $95.00 price target on shares of Danaher Corporation in a research note on Friday, August 4th. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 25th. Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. Finally, Deutsche Bank AG reaffirmed a “buy” rating and set a $97.00 price target on shares of Danaher Corporation in a research note on Wednesday, June 21st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. Danaher Corporation has a consensus rating of “Buy” and an average target price of $92.72.
TRADEMARK VIOLATION WARNING: This story was published by Daily Political and is owned by of Daily Political. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/09/22/savant-capital-llc-has-378000-stake-in-danaher-corporation-dhr.html.
Shares of Danaher Corporation (DHR) opened at 86.42 on Friday. The firm has a 50-day moving average of $82.99 and a 200-day moving average of $84.20. The firm has a market capitalization of $60.04 billion, a PE ratio of 27.58 and a beta of 1.03. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.62.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. During the same period in the prior year, the business earned $0.90 EPS. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. Equities analysts anticipate that Danaher Corporation will post $3.95 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be issued a $0.14 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.65%. Danaher Corporation’s dividend payout ratio (DPR) is presently 17.83%.
Danaher Corporation Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.